Literature DB >> 1728930

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.

J D Neaton1, D Wentworth.   

Abstract

To assess the combined influence of blood pressure (BP), serum cholesterol level, and cigarette smoking on death from coronary heart disease (CHD) and to describe how these associations vary with age, data on those factors and on mortality for 316,099 men screened for the Multiple Risk Factor Intervention Trial (MRFIT) were examined. Vital status of participants has been determined after an average follow-up of 12 years; 6327 deaths from CHD have been identified. Strong graded relationships between serum cholesterol levels above 4.65 mmol/L (180 mg/dL), systolic BP above 110 mm Hg, and diastolic BP above 70 mm Hg and mortality due to CHD were evident. Smokers with serum cholesterol and systolic BP levels in the highest quintiles had CHD death rates that were approximately 20 times greater than nonsmoking men with systolic BP and cholesterol levels in the lowest quintile. Systolic and diastolic BP, serum cholesterol level, and cigarettes per day were significant predictors of death due to CHD in all age groups. Systolic BP was a stronger predictor than diastolic BP. These results, together with the findings of clinical trials, offer strong support for intensified preventive efforts in all age groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1728930

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  169 in total

1.  Predictors of continued smoking over 25 years of follow-up in the normative aging study.

Authors:  B L Nordstrom; T Kinnunen; C H Utman; E A Krall; P S Vokonas; A J Garvey
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

Review 2.  Systolic hypertension and cardiovascular risk reduction: a clinical review.

Authors:  W C Cushman
Journal:  Curr Hypertens Rep       Date:  2001-09       Impact factor: 5.369

Review 3.  The need to lower systolic blood pressure.

Authors:  S Shrivastava; M S Kochar
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

4.  Unmet needs in hypertension: challenges and opportunities.

Authors:  J D Jackson; P Merat
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

Review 5.  Epidemiology of risk factors for hypertension: implications for prevention and therapy.

Authors:  M Kornitzer; M Dramaix; G De Backer
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 6.  Resource utilisation in the management of dyslipidaemia.

Authors:  T D Szucs
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

Review 7.  Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review.

Authors:  R Padwal; S E Straus; F A McAlister
Journal:  BMJ       Date:  2001-04-21

8.  Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.

Authors:  Le Kang; Weijie Chen; Nicholas A Petrick; Brandon D Gallas
Journal:  Stat Med       Date:  2014-11-17       Impact factor: 2.373

Review 9.  Hypertension in the elderly.

Authors:  M Pestana
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

10.  Trial design: blood pressure control and weight gain prevention in prehypertensive and hypertensive smokers: the treatment and prevention study.

Authors:  Mark W Vander Weg; Robert C Klesges; Jon O Ebbert; Ellen J Lichty; Margaret DeBon; Frederick North; Darrell R Schroeder; Patricia M Dubbert
Journal:  Contemp Clin Trials       Date:  2007-07-19       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.